Published in J Med Genet on November 01, 2005
Leaky Ca2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice. J Clin Invest (2008) 2.45
Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis. Circ Res (2011) 2.37
Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. J Am Coll Cardiol (2011) 1.89
Catecholaminergic polymorphic ventricular tachycardia in children: analysis of therapeutic strategies and outcomes from an international multicenter registry. Circ Arrhythm Electrophysiol (2015) 1.56
Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to β-adrenergic stimulation. J Cell Mol Med (2012) 1.55
Antiarrhythmic Effects of Dantrolene in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia and Replication of the Responses Using iPSC Models. PLoS One (2015) 1.53
Postpacing abnormal repolarization in catecholaminergic polymorphic ventricular tachycardia associated with a mutation in the cardiac ryanodine receptor gene. Heart Rhythm (2011) 1.46
Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia. Circ Arrhythm Electrophysiol (2011) 1.44
Inherited calcium channelopathies in the pathophysiology of arrhythmias. Nat Rev Cardiol (2012) 1.44
Leaky RyR2 channels unleash a brainstem spreading depolarization mechanism of sudden cardiac death. Proc Natl Acad Sci U S A (2016) 1.39
Ryanodine receptor channelopathies. Pflugers Arch (2010) 1.33
Determinants of incomplete penetrance and variable expressivity in heritable cardiac arrhythmia syndromes. Transl Res (2012) 1.25
Paradoxical effect of increased diastolic Ca(2+) release and decreased sinoatrial node activity in a mouse model of catecholaminergic polymorphic ventricular tachycardia. Circulation (2012) 1.19
The cardiac conduction system. Circulation (2011) 1.11
Ryanodine receptor-mediated arrhythmias and sudden cardiac death. Pharmacol Ther (2009) 1.08
Calsequestrin 2 and arrhythmias. Am J Physiol Heart Circ Physiol (2011) 1.08
Catecholaminergic polymorphic ventricular tachycardia. Eur J Pediatr (2010) 1.08
Sudden infant death syndrome in mice with an inherited mutation in RyR2. Circ Arrhythm Electrophysiol (2009) 1.04
Physiological consequences of the P2328S mutation in the ryanodine receptor (RyR2) gene in genetically modified murine hearts. Acta Physiol (Oxf) (2008) 0.98
A case of catecholaminergic polymorphic ventricular tachycardia. Yonsei Med J (2009) 0.98
Accelerated sinus rhythm prevents catecholaminergic polymorphic ventricular tachycardia in mice and in patients. Circ Res (2013) 0.91
Genetic testing in heritable cardiac arrhythmia syndromes: differentiating pathogenic mutations from background genetic noise. Curr Opin Cardiol (2013) 0.87
Acute atrial arrhythmogenicity and altered Ca(2+) homeostasis in murine RyR2-P2328S hearts. Cardiovasc Res (2010) 0.87
The EF-hand Ca2+ Binding Domain Is Not Required for Cytosolic Ca2+ Activation of the Cardiac Ryanodine Receptor. J Biol Chem (2015) 0.86
Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia. Pediatr Cardiol (2012) 0.85
Arrhythmogenesis in a catecholaminergic polymorphic ventricular tachycardia mutation that depresses ryanodine receptor function. Proc Natl Acad Sci U S A (2015) 0.85
A quantitative analysis of the effect of cycle length on arrhythmogenicity in hypokalaemic Langendorff-perfused murine hearts. Pflugers Arch (2007) 0.84
Ion Channels in the Heart. Compr Physiol (2015) 0.83
Abnormal Ca(2+) homeostasis, atrial arrhythmogenesis, and sinus node dysfunction in murine hearts modeling RyR2 modification. Front Physiol (2013) 0.83
Modeling Catecholaminergic Polymorphic Ventricular Tachycardia using Induced Pluripotent Stem Cell-derived Cardiomyocytes. Rambam Maimonides Med J (2012) 0.82
Targeted ablation of cardiac sympathetic neurons reduces resting, reflex and exercise-induced sympathetic activation in conscious rats. Am J Physiol Heart Circ Physiol (2009) 0.82
Cardiac Channelopathies and Sudden Death: Recent Clinical and Genetic Advances. Biology (Basel) (2017) 0.81
Biology of the Sinus Node and its Disease. Arrhythm Electrophysiol Rev (2015) 0.81
Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations. J Cell Mol Med (2015) 0.81
Sudden unexpected death in epilepsy genetics: Molecular diagnostics and prevention. Epilepsia (2016) 0.81
Calcium transient and sodium-calcium exchange current in human versus rabbit sinoatrial node pacemaker cells. ScientificWorldJournal (2013) 0.80
Sinus node dysfunction in catecholaminergic polymorphic ventricular tachycardia: risk factor and potential therapeutic target? Trends Cardiovasc Med (2014) 0.80
Targeted ablation of cardiac sympathetic neurons reduces the susceptibility to ischemia-induced sustained ventricular tachycardia in conscious rats. Am J Physiol Heart Circ Physiol (2010) 0.80
Mechanisms of sudden unexplained death in epilepsy. Curr Opin Neurol (2015) 0.79
Alternans in genetically modified langendorff-perfused murine hearts modeling catecholaminergic polymorphic ventricular tachycardia. Front Physiol (2010) 0.79
Genetics of inherited primary arrhythmia disorders. Appl Clin Genet (2015) 0.77
Follow-up with exercise test of effort-induced ventricular arrhythmias linked to ryanodine receptor type 2 gene mutations. Am J Cardiol (2012) 0.77
Just sinus bradycardia or something more serious? Case Rep Pediatr (2013) 0.76
Carvedilol analog modulates both basal and stimulated sinoatrial node automaticity. Heart Vessels (2013) 0.76
Risk stratification in electrical cardiomyopathies. Herz (2009) 0.76
Arrhythmia-associated cardiac Ca²(+) cycling proteins and gene mutations. Wien Med Wochenschr (2012) 0.76
The design and use of an optical mapping system for the study of intracardiac electrical signaling. Indian Pacing Electrophysiol J (2012) 0.75
RyR2R420Q catecholaminergic polymorphic ventricular tachycardia mutation induces bradycardia by disturbing the coupled clock pacemaker mechanism. JCI Insight (2017) 0.75
Array comparative genomic hybridization identifies a heterozygous deletion of exon 3 of the RYR2 gene. Ups J Med Sci (2015) 0.75
Enhanced Cytosolic Ca2+ Activation Underlies a Common Defect of Central Domain Cardiac Ryanodine Receptor Mutations Linked to Arrhythmias. J Biol Chem (2016) 0.75
Catecholaminergic polymorphic ventricular tachycardia in a patient with recurrent exertional syncope. Korean Circ J (2012) 0.75
SK4 K(+) channels are therapeutic targets for the treatment of cardiac arrhythmias. EMBO Mol Med (2017) 0.75
Inherited bradyarrhythmia: A diverse genetic background. J Arrhythm (2015) 0.75
Evaluation and management of bradycardia in neonates and children. Eur J Pediatr (2016) 0.75
[Catecholaminergic polymorphic ventricular tachycardia]. Herzschrittmacherther Elektrophysiol (2012) 0.75
[Ventricular tachycardia under stress : Characteristic symptom or prognostic relevance?]. Herzschrittmacherther Elektrophysiol (2013) 0.75
Murine Electrophysiological Models of Cardiac Arrhythmogenesis. Physiol Rev (2017) 0.75
At the Heart of the Pregnancy: What Prenatal and Cardiovascular Genetic Counselors Need to Know about Maternal Heart Disease. J Genet Couns (2017) 0.75
Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation (2001) 7.47
A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet (1998) 4.75
Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation (1995) 4.19
A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet (1997) 3.79
A single Na(+) channel mutation causing both long-QT and Brugada syndromes. Circ Res (2000) 3.68
Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am J Hum Genet (2001) 2.66
Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry. Circulation (2010) 2.53
Identification of a possible pathogenic link between congenital long QT syndrome and epilepsy. Neurology (2008) 2.21
Electrophysiological characterization of SCN5A mutations causing long QT (E1784K) and Brugada (R1512W and R1432G) syndromes. Cardiovasc Res (2000) 2.19
Is T-wave alternans testing feasible in candidates for prophylactic implantable defibrillators? Neth Heart J (2011) 1.89
Bibliometric data in clinical cardiology revisited. The case of 37 Dutch professors. Neth Heart J (2011) 1.79
Increased tumour risk for BWS patients correlates with aberrant H19 and not KCNQ1OT1 methylation: occurrence of KCNQ1OT1 hypomethylation in familial cases of BWS. Hum Mol Genet (2001) 1.79
KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome. Circulation (1997) 1.76
Genotype-phenotype correlations of 39 patients with Cornelia De Lange syndrome: the Dutch experience. J Med Genet (2005) 1.72
Homozygous premature truncation of the HERG protein : the human HERG knockout. Circulation (1999) 1.71
CONCOR, an initiative towards a national registry and DNA-bank of patients with congenital heart disease in the Netherlands: rationale, design, and first results. Eur J Epidemiol (2005) 1.70
Genomic organization of the KCNQ1 K+ channel gene and identification of C-terminal mutations in the long-QT syndrome. Circ Res (1999) 1.70
Epidemiology of desmin and cardiac actin gene mutations in a european population of dilated cardiomyopathy. Eur Heart J (2000) 1.68
Novel Brugada syndrome-causing mutation in ion-conducting pore of cardiac Na+ channel does not affect ion selectivity properties. Acta Physiol Scand (2005) 1.67
Long-term follow-up of children and adolescents with syncope; predictor of syncope recurrence. Eur Heart J (2001) 1.62
Mapping of a novel gene for familial hypertrophic cardiomyopathy to chromosome 11. Nat Genet (1993) 1.58
Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome. Nat Genet (2001) 1.56
Properties of KvLQT1 K+ channel mutations in Romano-Ward and Jervell and Lange-Nielsen inherited cardiac arrhythmias. EMBO J (1997) 1.55
[Initial diagnostic strategy in the case of transient losses of consciousness: the importance of the medical history]. Ned Tijdschr Geneeskd (2003) 1.55
Genetic knowledge and counselling skills of Dutch cardiologists: sufficient for the genomics era? Eur Heart J (2003) 1.52
Mutations in the T (brachyury) gene cause a novel syndrome consisting of sacral agenesis, abnormal ossification of the vertebral bodies and a persistent notochordal canal. J Med Genet (2013) 1.51
Tissue Doppler echocardiography in patients with long QT syndrome. Eur J Echocardiogr (2003) 1.49
[Genetic identification of patients and families with a long-QT syndrome: large regional differences in the result of 10 years]. Ned Tijdschr Geneeskd (2007) 1.46
Asystolic cardiac arrest during head-up tilt test: incidence and therapeutic implications. Pacing Clin Electrophysiol (1997) 1.46
Immediate and mid-term results of repeat percutaneous mitral commissurotomy for restenosis following earlier percutaneous mitral commissurotomy. Eur Heart J (2000) 1.45
Novel mechanism for Brugada syndrome: defective surface localization of an SCN5A mutant (R1432G). Circ Res (2001) 1.44
Severity of the ductal shunt: a comparison of different markers. Arch Dis Child Fetal Neonatal Ed (2005) 1.43
Novel mutations in KvLQT1 that affect Iks activation through interactions with Isk. Cardiovasc Res (2000) 1.42
The works of Dirk Durrer (1918-1984). Neth Heart J (2012) 1.39
[Medication for ADHD and the risk of cardiovascular mortality]. Ned Tijdschr Geneeskd (2006) 1.39
Molecular basis of familial cardiomyopathies. Circulation (1995) 1.36
The Hirsch-index: a simple, new tool for the assessment of scientific output of individual scientists: The case of Dutch professors in clinical cardiology. Neth Heart J (2009) 1.30
Mutation in the human acetylcholinesterase-associated collagen gene, COLQ, is responsible for congenital myasthenic syndrome with end-plate acetylcholinesterase deficiency (Type Ic). Am J Hum Genet (1998) 1.29
Clinical and histologic findings in autosomal centronuclear myopathy. Neurology (2004) 1.28
C-terminal HERG mutations: the role of hypokalemia and a KCNQ1-associated mutation in cardiac event occurrence. Circulation (1999) 1.26
Epigenotype-phenotype correlations in Silver-Russell syndrome. J Med Genet (2010) 1.24
Recessive RYR1 mutations cause unusual congenital myopathy with prominent nuclear internalization and large areas of myofibrillar disorganization. Neuropathol Appl Neurobiol (2011) 1.22
The Dutch Fabry cohort: diversity of clinical manifestations and Gb3 levels. J Inherit Metab Dis (2007) 1.21
Multiple genetic loci within 11p15 defined by Beckwith-Wiedemann syndrome rearrangement breakpoints and subchromosomal transferable fragments. Proc Natl Acad Sci U S A (1995) 1.19
Paroxysmal vagal overactivity, apparent life-threatening event and sudden infant death. Biol Neonate (2000) 1.15
Homozygous SCN5A mutation in long-QT syndrome with functional two-to-one atrioventricular block. Circ Res (2001) 1.14
The use of genotype-phenotype correlations in mutation analysis for the long QT syndrome. J Med Genet (2003) 1.13
[Double outlet left ventricle: a rare and unusual cardiopathy. Apropos of 7 new cases]. Arch Mal Coeur Vaiss (1996) 1.12
Exclusion of HRAS from long QT locus. Nat Genet (1994) 1.11
The cardiac sodium channel displays differential distribution in the conduction system and transmural heterogeneity in the murine ventricular myocardium. Basic Res Cardiol (2009) 1.11
Low incidence of cardiac events with beta-blocking therapy in children with long QT syndrome. Eur Heart J (2004) 1.11
Giant axonal neuropathy: clinical and genetic study in six cases. J Neurol Neurosurg Psychiatry (2005) 1.10
Two cases of severe neonatal hypertrophic cardiomyopathy caused by compound heterozygous mutations in the MYBPC3 gene. J Med Genet (2006) 1.10
Confirmation of associations between ion channel gene SNPs and QTc interval duration in healthy subjects. Eur J Hum Genet (2007) 1.08
The IGSF1 deficiency syndrome: characteristics of male and female patients. J Clin Endocrinol Metab (2013) 1.05
The influence of the angiotensin I converting enzyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation. J Mol Cell Cardiol (1997) 1.05
Localization of merosin-negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping. Hum Mol Genet (1994) 1.04
Impact of cardiac complications on outcome after aneurysmal subarachnoid hemorrhage: a meta-analysis. Neurology (2009) 1.00
Splicing mutations in KCNQ1: a mutation hot spot at codon 344 that produces in frame transcripts. Circulation (1999) 1.00
Report of the Fifth International Workshop on Human Chromosome 11 Mapping 1996. Cytogenet Cell Genet (1996) 0.98
Multi-minicore disease--searching for boundaries: phenotype analysis of 38 cases. Ann Neurol (2000) 0.98
Family and population strategies for screening and counselling of inherited cardiac arrhythmias. Ann Med (2004) 0.98
Two patients with 'Dropped head syndrome' due to mutations in LMNA or SEPN1 genes. Neuromuscul Disord (2005) 0.98
New POMT2 mutations causing congenital muscular dystrophy: identification of a founder mutation. Neurology (2007) 0.97
Substitution of a conserved cysteine-996 in a cysteine-rich motif of the laminin alpha2-chain in congenital muscular dystrophy with partial deficiency of the protein. Am J Hum Genet (1996) 0.96
Human synemin gene generates splice variants encoding two distinct intermediate filament proteins. Eur J Biochem (2001) 0.96
Dynamin 2-related centronuclear myopathy: clinical, histological and genetic aspects of further patients and review of the literature. Clin Neuropathol (2009) 0.96
A monozygotic twin pair with highly discordant Gaucher phenotypes. Blood Cells Mol Dis (2010) 0.95
Nitroglycerine ointment as aid to venous cannulation in children. J Pediatr (1987) 0.95
[Congenital long QT syndrome. The value of genetics in prognostic evaluation]. Arch Mal Coeur Vaiss (1999) 0.95
Fever-triggered ventricular arrhythmias in Brugada syndrome and type 2 long-QT syndrome. Neth Heart J (2010) 0.94
First experience with the wearable cardioverter defibrillator in the Netherlands. Neth Heart J (2012) 0.94
Recurrent and founder mutations in the Netherlands-Phospholamban p.Arg14del mutation causes arrhythmogenic cardiomyopathy. Neth Heart J (2013) 0.94
[Congenital muscular dystrophy with merosin deficiency: clinical, histopathological, immunocytochemical and genetic analysis]. Rev Neurol (Paris) (1996) 0.94
Left cardiac sympathetic denervation in the Netherlands for the treatment of inherited arrhythmia syndromes. Neth Heart J (2014) 0.93
Two-dimensional echocardiographic and color Doppler measurements of atrial septal defect, and comparison with the balloon-stretched diameter. Am J Cardiol (1993) 0.93
The ergometrine test: effects on esophageal motility in patients with chest pain and normal coronary arteries. Can J Cardiol (1987) 0.93
Identification of a new locus for a peculiar form of congenital muscular dystrophy with early rigidity of the spine, on chromosome 1p35-36. Am J Hum Genet (1998) 0.93
Ehlers-Danlos syndrome due to tenascin-X deficiency: muscle weakness and contractures support overlap with collagen VI myopathies. Am J Med Genet A (2007) 0.92
Founder mutations in hypertrophic cardiomyopathy patients in the Netherlands. Neth Heart J (2010) 0.92
[Familial scimitar syndrome]. Arch Mal Coeur Vaiss (1993) 0.92
Phenotypic discordance upon paternal or maternal transmission of duplications of the 11p15 imprinted regions. Eur J Med Genet (2009) 0.92